中文简体
中文繁体
English
العربية
ABOUT IASO
Company Overview
Management Team
Scientific Advisory Board
Partnership
SCIENCE & PRODUCTS
Pipeline
Technology Platforms
Manufacturing
Publictaions
Expanded Access
NEWS
Press Release
Media Report
CAREERS
Working at IASO
Opportunities
CONTACT
NEWS
Press Release
Media Report
Search
14
2020-10
IASO Bio Appoints Dr. Biao Zheng as Chief Scientific Officer and Dr. Wen Wang as Chief Medical Officer
23
2020-03
IASO Biotherapeutics Raises $60 Million in Series B Financing led by GL Ventures to Advance Cell Therapies for Cancer Care
11
2019-09
NMPA Approves IND Application for CT103A, A Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma codeveloped by IASO BIO and Innovent Bio
18
2019-06
Clinical Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by IASO BIO and Innovent Presented at the 2019 ASCO and EHA Annual Meetings
<
5
6
7
8
9
>
